These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16489930)

  • 1. Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product.
    Kaur G; Hollingshead M; Holbeck S; Schauer-Vukasinović V; Camalier RF; Dömling A; Agarwal S
    Biochem J; 2006 Jun; 396(2):235-42. PubMed ID: 16489930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy.
    Herrmann J; Elnakady YA; Wiedmann RM; Ullrich A; Rohde M; Kazmaier U; Vollmar AM; Müller R
    PLoS One; 2012; 7(5):e37416. PubMed ID: 22616003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular disrupting activity and the mechanism of action of EHT 6706, a novel anticancer tubulin polymerization inhibitor.
    Belzacq-Casagrande AS; Bachelot F; De Oliveira C; Coutadeur S; Maurier-Mahé F; Throo E; Chauvignac C; Pognante L; Petibon A; Taverne T; Beausoleil E; Leblond B; Pando MP; Désiré L
    Invest New Drugs; 2013 Apr; 31(2):304-19. PubMed ID: 22878926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric tubulysin-peptide nanoparticles with potent antitumor activity.
    Schluep T; Gunawan P; Ma L; Jensen GS; Duringer J; Hinton S; Richter W; Hwang J
    Clin Cancer Res; 2009 Jan; 15(1):181-9. PubMed ID: 19118045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of tubulysin, an antimitotic peptide from myxobacteria.
    Khalil MW; Sasse F; Lünsdorf H; Elnakady YA; Reichenbach H
    Chembiochem; 2006 Apr; 7(4):678-83. PubMed ID: 16491500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
    Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
    Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of tubulysin D analogs related to stereoisomers of tubuvaline.
    Shibue T; Okamoto I; Morita N; Morita H; Hirasawa Y; Hosoya T; Tamura O
    Bioorg Med Chem Lett; 2011 Jan; 21(1):431-4. PubMed ID: 21106374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiproliferative evaluation of pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivatives.
    Popowycz F; Schneider C; Debonis S; Skoufias DA; Kozielski F; Galmarini CM; Joseph B
    Bioorg Med Chem; 2009 May; 17(9):3471-8. PubMed ID: 19349183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PM060184, a new tubulin binding agent with potent antitumor activity including P-glycoprotein over-expressing tumors.
    Martínez-Díez M; Guillén-Navarro MJ; Pera B; Bouchet BP; Martínez-Leal JF; Barasoain I; Cuevas C; Andreu JM; García-Fernández LF; Díaz JF; Avilés P; Galmarini CM
    Biochem Pharmacol; 2014 Apr; 88(3):291-302. PubMed ID: 24486569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubulysin analogs incorporating desmethyl and dimethyl tubuphenylalanine derivatives.
    Balasubramanian R; Raghavan B; Steele JC; Sackett DL; Fecik RA
    Bioorg Med Chem Lett; 2008 May; 18(9):2996-9. PubMed ID: 18411048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
    Yu DH; Liu YR; Luan X; Liu HJ; Gao YG; Wu H; Fang C; Chen HZ
    Bioconjug Chem; 2015 Aug; 26(8):1702-12. PubMed ID: 26076081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of diarylthiazole derivatives as antimitotic and antivascular agents with potent antitumor activity.
    Wang F; Yang Z; Liu Y; Ma L; Wu Y; He L; Shao M; Yu K; Wu W; Pu Y; Nie C; Chen L
    Bioorg Med Chem; 2015 Jul; 23(13):3337-50. PubMed ID: 25937236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic and Anticancer Properties of Bifunctional Ruthenium(II)-p-Cymene Complexes: Influence of Pendant Perfluorous Chains.
    Nowak-Sliwinska P; Clavel CM; Păunescu E; te Winkel MT; Griffioen AW; Dyson PJ
    Mol Pharm; 2015 Aug; 12(8):3089-96. PubMed ID: 26158308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.
    Loganzo F; Discafani CM; Annable T; Beyer C; Musto S; Hari M; Tan X; Hardy C; Hernandez R; Baxter M; Singanallore T; Khafizova G; Poruchynsky MS; Fojo T; Nieman JA; Ayral-Kaloustian S; Zask A; Andersen RJ; Greenberger LM
    Cancer Res; 2003 Apr; 63(8):1838-45. PubMed ID: 12702571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway.
    Ho CH; Hsu JL; Liu SP; Hsu LC; Chang WL; Chao CC; Guh JH
    Prostate; 2015 Sep; 75(13):1454-66. PubMed ID: 26180030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents.
    Konson A; Pradeep S; Seger R
    Cancer Res; 2010 Aug; 70(15):6247-57. PubMed ID: 20610633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition.
    Viola G; Cecconet L; Leszl A; Basso G; Brun P; Salvador A; Dall'Acqua F; Diana P; Barraja P; Cirrincione G
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1235-51. PubMed ID: 19363609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
    Cai P; Lu P; Sharom FJ; Fang WS
    Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms.
    Coudray AM; Louvet C; Kornprobst M; Raymond E; André T; Tournigand C; Faivre S; De Gramont A; Larsen AK; Gespach C
    Int J Oncol; 2005 Aug; 27(2):553-61. PubMed ID: 16010439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.